Clinical trial
Oxytocin as Adjunctive Treatment of Schizophrenia
NCT01568528 is registered in ClinicalTrials.gov with Emory University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Oxytocin as Adjunctive Treatment of Schizophrenia
- Lead sponsor
- Emory University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 31, 2013
- Completion date
- March 15, 2017
- Enrollment
- 39 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.